Your browser is no longer supported. Please, upgrade your browser.
Settings
AVDL Avadel Pharmaceuticals plc daily Stock Chart
AVDL [NASD]
Avadel Pharmaceuticals plc
Index- P/E- EPS (ttm)-1.00 Insider Own2.60% Shs Outstand41.69M Perf Week5.82%
Market Cap409.40M Forward P/E48.37 EPS next Y0.20 Insider Trans- Shs Float40.52M Perf Month5.59%
Income-41.30M PEG- EPS next Q-0.05 Inst Own59.00% Short Float0.93% Perf Quarter-0.71%
Sales150.20M P/S2.73 EPS this Y-204.20% Inst Trans-15.65% Short Ratio2.54 Perf Half Y-15.20%
Book/sh1.02 P/B9.63 EPS next Y350.00% ROA-16.50% Target Price19.17 Perf Year-18.71%
Cash/sh3.70 P/C2.65 EPS next 5Y- ROE-82.40% 52W Range8.61 - 15.45 Perf YTD-5.49%
Dividend- P/FCF23.13 EPS past 5Y-23.00% ROI-20.50% 52W High-36.44% Beta1.59
Dividend %- Quick Ratio2.90 Sales past 5Y35.70% Gross Margin91.20% 52W Low14.05% ATR0.39
Employees165 Current Ratio2.90 Sales Q/Q-3.40% Oper. Margin-3.30% RSI (14)52.92 Volatility3.64% 4.13%
OptionableYes Debt/Eq3.23 EPS Q/Q-91.70% Profit Margin-27.50% Rel Volume1.92 Prev Close9.83
ShortableYes LT Debt/Eq3.22 EarningsMay 09 BMO Payout- Avg Volume147.37K Price9.82
Recom1.60 SMA202.09% SMA50-0.20% SMA200-12.49% Volume283,026 Change-0.10%
Apr-24-17 04:05PM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Apr-17-17 04:03PM  Avadel Pharmaceuticals to Report First Quarter 2017 Results GlobeNewswire
Apr-01-17 01:04PM  AVADEL PHARMACEUTICALS PLC Financials
Mar-31-17 05:08PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial Statement
Mar-30-17 04:03PM  Avadel Pharmaceuticals Announces Planned Reduction of French Workforce GlobeNewswire
Mar-28-17 05:24PM  AVADEL PHARMACEUTICALS PLC Files SEC form 10-K, Annual Report
Mar-17-17 06:03AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.53%
Mar-07-17 04:08PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibi
07:06AM  Avadel tops Street 4Q forecasts
07:00AM  Avadel Pharmaceuticals Announces $25 Million Share Repurchase Program GlobeNewswire
06:30AM  Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results GlobeNewswire
Mar-02-17 10:01AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
07:30AM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-24-17 08:30AM  Avadel Pharmaceuticals (AVDL) Looks Good: Stock Up 5.3% Zacks
Feb-16-17 06:37AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
Feb-14-17 07:30AM  Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results GlobeNewswire
Feb-06-17 03:55PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
07:30AM  Avadel Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire
Jan-11-17 04:05PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-06-17 01:52PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events -6.66%
Jan-05-17 11:57AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.18%
08:18AM  CORRECTING and REPLACING Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
07:30AM  Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
Jan-03-17 04:03PM  Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer GlobeNewswire +5.39%
07:30AM  Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc GlobeNewswire
Dec-19-16 03:38PM  FLAMEL TECHNOLOGIES SA Files SEC form 8-K, Other Events
Avadel Pharmaceuticals PLC is a pharmaceutical company engaged in drug delivery and formulation development to create safer and more efficacious pharmaceutical products.